• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于ceRNA网络的甲状腺癌非编码RNA相关预后生物标志物的鉴定

Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.

作者信息

Fang Xin, Chen Xiliang, Gao Jingquan, Tong Liquan

机构信息

Department of General Surgery II, Daqing Oilfield General Hospital, Daqing, China.

Department of Rehabilitation, Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.

出版信息

Front Genet. 2023 Apr 20;14:1157438. doi: 10.3389/fgene.2023.1157438. eCollection 2023.

DOI:10.3389/fgene.2023.1157438
PMID:37153003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10158935/
Abstract

Thyroid cancer (THCA) has become a serious malignant tumor worldwide. Identification of non-coding RNA related regulators is very necessary to improve the knowledge of THCA treatment. The aim of this study was to identify novel therapeutic targets and prognosis biomarkers for predicting pathological characteristics and subsequently treating THCA. We investigated the alterations of miRNAs, mRNAs and lncRNAs in THCA. Functional enrichment and clustering analysis were conducted for these aberrantly expressed RNAs. Multiple interaction networks among miRNAs, mRNAs and lncRNAs were constructed and the functional modules associated with THCA patients' prognosis were identified. Furthermore, we evaluated the prognostic roles of the important miRNAs, mRNAs and lncRNAs in THCA and investigated the regulatory potential of non-coding RNAs on immune cell infiltration. We firstly identified that and could significantly classify patients into high/low risk groups, which may be potential prognosis biomarkers of THCA. Secondly, we constructed a THCA-related miRNA-mRNA network, which displayed small world network topological characters. Two THCA-related functional modules were identified from the miRNA-mRNA network by MCODE. Results showed that two modules could implicate in known cancer pathways, such as apoptosis and focal adhesion. Thirdly, a THCA-related miRNA-lncRNA network was constructed. A subnetwork of miRNA-lncRNA network showed strong prognosis effect in THCA. Fourthly, we constructed a THCA-related mRNA-lncRNA network and detected several typical lncRNA-miRNA-mRNA crosstalk, such as , , and , which had good prognosis effect in THCA. Immune infiltration results showed that lncRNAs LA16c-329F2, RP11-395N3, RP11-423H2, RP11-399B17 and RP11-1036E20 were high related to neutrophil and dendritic cell infiltration. Non-coding RNA-mediated gene regulatory network has the strong regulatory potential in pathological processes of THCA. All these results could help us uncover the non-coding RNA-mediated regulatory mechanism in THCA.

摘要

甲状腺癌(THCA)已成为全球范围内一种严重的恶性肿瘤。识别与非编码RNA相关的调节因子对于增进对THCA治疗的认识非常必要。本研究的目的是识别新的治疗靶点和预后生物标志物,以预测病理特征并随后治疗THCA。我们研究了THCA中miRNA、mRNA和lncRNA的变化。对这些异常表达的RNA进行了功能富集和聚类分析。构建了miRNA、mRNA和lncRNA之间的多个相互作用网络,并识别出与THCA患者预后相关的功能模块。此外,我们评估了重要的miRNA、mRNA和lncRNA在THCA中的预后作用,并研究了非编码RNA对免疫细胞浸润的调节潜力。我们首先确定, 和 可将患者显著分为高/低风险组,这可能是THCA的潜在预后生物标志物。其次,我们构建了一个与THCA相关的miRNA-mRNA网络,该网络显示出小世界网络拓扑特征。通过MCODE从miRNA-mRNA网络中识别出两个与THCA相关的功能模块。结果表明,这两个模块可能涉及已知的癌症途径,如细胞凋亡和粘着斑。第三,构建了一个与THCA相关的miRNA-lncRNA网络。miRNA-lncRNA网络的一个子网在THCA中显示出很强的预后作用。第四,我们构建了一个与THCA相关的mRNA-lncRNA网络,并检测到几个典型的lncRNA-miRNA-mRNA串扰,如 、 、 和 ,它们在THCA中具有良好的预后作用。免疫浸润结果表明,lncRNAs LA16c-329F2、RP11-395N3、RP11-423H2、RP11-399B17和RP11-!036E20与中性粒细胞和树突状细胞浸润高度相关。非编码RNA介导基因调控网络在THCA的病理过程中具有很强的调控潜力。所有这些结果有助于我们揭示THCA中非编码RNA介导的调控机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/914616ee232e/fgene-14-1157438-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/90a043d1b821/fgene-14-1157438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/12ed2e7b5b88/fgene-14-1157438-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/1577e487a1ce/fgene-14-1157438-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/f9ac023c0560/fgene-14-1157438-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/54268201bacd/fgene-14-1157438-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/914616ee232e/fgene-14-1157438-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/90a043d1b821/fgene-14-1157438-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/12ed2e7b5b88/fgene-14-1157438-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/1577e487a1ce/fgene-14-1157438-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/f9ac023c0560/fgene-14-1157438-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/54268201bacd/fgene-14-1157438-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fcf/10158935/914616ee232e/fgene-14-1157438-g006.jpg

相似文献

1
Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.基于ceRNA网络的甲状腺癌非编码RNA相关预后生物标志物的鉴定
Front Genet. 2023 Apr 20;14:1157438. doi: 10.3389/fgene.2023.1157438. eCollection 2023.
2
Comprehensive Analysis of miRNA-Mediated Regulatory Network and Identification of Prognosis Biomarkers in Rectal Cancer.直肠癌中miRNA介导的调控网络综合分析及预后生物标志物的鉴定
Front Genet. 2022 Apr 12;13:792984. doi: 10.3389/fgene.2022.792984. eCollection 2022.
3
Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma.鉴定甲状腺癌中与肿瘤微环境相关的预后生物标志物。
Sci Rep. 2021 Aug 10;11(1):16239. doi: 10.1038/s41598-021-90538-3.
4
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.对喉鳞状细胞癌中lncRNAs、mRNAs和miRNAs的差异表达谱进行综合分析,以构建ceRNA网络并鉴定潜在生物标志物。
J Cell Biochem. 2019 Oct;120(10):17963-17974. doi: 10.1002/jcb.29063. Epub 2019 May 24.
5
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞癌中异常表达的 lncRNAs 和 miRNAs 谱的综合分析及其相关 ceRNA 网络。
Pathol Oncol Res. 2020 Jul;26(3):1935-1945. doi: 10.1007/s12253-019-00780-4. Epub 2020 Jan 2.
6
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.肺鳞状细胞癌中预后相关 lncRNAs、miRNAs 和 mRNAs 形成竞争内源性 RNA 网络的全基因组分析。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1711-1723. doi: 10.1007/s00432-020-03224-8. Epub 2020 Apr 30.
7
The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.多囊卵巢综合征患者壁层颗粒细胞中的lncRNA-miRNA-mRNA ceRNA网络:基于基因表达综合数据库数据的分析
Ann Transl Med. 2021 Jul;9(14):1156. doi: 10.21037/atm-21-2696.
8
A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.基于加权基因共表达网络分析构建用于葡萄膜黑色素瘤预后的新型 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络。
Life Sci. 2020 Nov 1;260:118409. doi: 10.1016/j.lfs.2020.118409. Epub 2020 Sep 11.
9
The analysis of a ceRNA network and the correlation between lncRNA, miRNA, and mRNA in bladder cancer.膀胱癌中ceRNA网络及lncRNA、miRNA与mRNA之间的相关性分析。
Transl Cancer Res. 2020 Feb;9(2):869-881. doi: 10.21037/tcr.2019.12.27.
10
Identification of m6A-related lncRNAs for thyroid cancer recurrence.用于甲状腺癌复发的m6A相关长链非编码RNA的鉴定
Gland Surg. 2023 Jan 1;12(1):39-53. doi: 10.21037/gs-22-678. Epub 2023 Jan 6.

本文引用的文献

1
LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.长链非编码 RNA H19 是甲状腺癌的一种潜在生物标志物,并与免疫浸润相关。
Clin Exp Med. 2023 Jul;23(3):841-851. doi: 10.1007/s10238-022-00853-w. Epub 2022 Jul 9.
2
LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p.长链非编码 RNA-MIAT 通过海绵吸附 miR-150-5p 促进甲状腺癌的进展和功能作为 ceRNA 靶向 EZH2。
Cell Death Dis. 2021 Nov 22;12(12):1097. doi: 10.1038/s41419-021-04386-0.
3
Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
长链基因内非编码RNA p53诱导转录本(LINC-PINT)作为癌症中的一种新型预后指标和治疗靶点。
Biomed Pharmacother. 2021 Nov;143:112127. doi: 10.1016/j.biopha.2021.112127. Epub 2021 Aug 30.
4
LncSEA: a platform for long non-coding RNA related sets and enrichment analysis.LncSEA:一个长非编码 RNA 相关集和富集分析的平台。
Nucleic Acids Res. 2021 Jan 8;49(D1):D969-D980. doi: 10.1093/nar/gkaa806.
5
Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma.长链非编码 RNA H19 的表达预测微创滤泡状甲状腺癌的远处转移。
Bioengineered. 2019 Dec;10(1):383-389. doi: 10.1080/21655979.2019.1658489.
6
MiRNA therapeutics based on logic circuits of biological pathways.基于生物通路逻辑电路的 miRNA 治疗。
BMC Bioinformatics. 2019 Nov 22;20(Suppl 9):344. doi: 10.1186/s12859-019-2881-7.
7
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.长链非编码RNA FOXD2-AS1作为一种竞争性内源性RNA,通过海绵吸附miR-7-5p来调节甲状腺癌中的端粒酶逆转录酶(TERT)表达。
Front Endocrinol (Lausanne). 2019 Apr 8;10:207. doi: 10.3389/fendo.2019.00207. eCollection 2019.
8
Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.长链非编码 RNA PCAT6 通过 HMGA2 信号靶向 miR-204 调节结直肠癌细胞对基于 5-氟尿嘧啶的化疗耐药性。
Cancer Med. 2019 May;8(5):2484-2495. doi: 10.1002/cam4.1809. Epub 2019 Apr 1.
9
LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.长链非编码 RNA HOXA-AS2 通过调节 miR-15a-5p/HOXA3 轴促进甲状腺乳头状癌的发生和进展。
Hum Gene Ther. 2019 May;30(5):618-631. doi: 10.1089/hum.2018.109. Epub 2019 Feb 26.
10
LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.长链非编码 RNA MT1JP 通过竞争性结合 miR-92a-3p 在胃癌中作为 ceRNA 调节 FBXW7。
Mol Cancer. 2018 May 2;17(1):87. doi: 10.1186/s12943-018-0829-6.